CancerNetwork Members: Login | Register
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Ethics

CONSULTATIONS IN ETHICS 

A Patient “Disrespected”

By Paul R. Helft, MD | August 9, 2012
Dr. Helft is an Associate Professor of Medicine at the Indiana University School of Medicine; his clinical work is based in the Gastrointestinal Oncology Program at the Indiana University Melvin and Bren Simon Cancer Center. Dr. Helft is also director of the Charles Warren Fairbanks Center for Medical Ethics at Indiana University Health in Indianapolis.

A 60-year-old immigrant from Germany is diagnosed with widely metastatic colon cancer.  His sigmoid tumor is nearly obstructing, and he undergoes a laparoscopic hand-assisted sigmoid colectomy, from which he recovers successfully. His staging CT scans demonstrate multiple bilobar liver metastases, bilateral small pulmonary nodules, and upper retroperitoneal lymphadenopathy.  The initial consultation focuses on a discussion of the extent of the patient’s disease, its incurability, and an approach to therapy that includes the use of multiple, sequential chemotherapy regimens aimed at improving his length and quality of life. The patient calls 2 weeks later and tells me that I “disrespected” him by only focusing on chemotherapy and not mentioning alternative treatments, including those offered at some of the well-known alternative treatment centers around the US. What ethical obligations should guide me in deciding whether I should continue to treat the patient? Do I have an ethical obligation to discuss alternative treatments with the patient?

Dr. Helft Responds


Paul R. Helft, MD

Two separate ethical questions are raised by this case. The first concerns the ethics of the doctor-patient relationship, and the second concerns obligations to discuss unproven therapies in the context of an informed consent discussion. 

(MORE: Don't Tell Me Anything Negative)

The patient’s claim that he felt “disrespected” because alternative strategies were not discussed suggests that the relationship may be irreparably damaged on account of the patient’s perception (which both came as a shock to the treating physician and was upsetting to him). Such incidents—irrespective of how the physician perceives their validity—can be extremely harmful to the creation and sustaining of a therapeutic relationship; they are particularly damaging at the beginning of such a relationship. However, with few exceptions (eg, a patient who verbally or physically threatens staff), a physician cannot sever the relationship—even though patients can fire their doctors. My worry in this case is that re-establishing trust with this patient is likely to be difficult given his perceptions of the first interaction with his physician. I also suspect that there is either a hidden cultural or linguistic issue (ie, what did the patient mean by “disrespected”, and did the physician understand his meaning as he understood it?) In any case, I feel that, ethically, severing the relationship is not an option for the treating physician, even though it would be within the patient’s rights to end it. I have debated whether it might be helpful for the physician to have an open discussion about the patient’s feelings of disrespect in an effort to repair the damage; ultimately, however, I don’t feel that such a discussion is likely to lead to a different perception, and it might come across as defensive, so my recommendation is that he not pursue such a conversation.

As for the question of whether discussing alternative therapies is something a physician is ethically obligated to do, I think the short answer is no. Those of us trained in, and who believe in, Western, scientifically-driven, allopathic medicine should not have to include discussions of unproven therapies as part of a comprehensive informed consent discussion. Offering an opinion about such treatments, when asked directly, certainly seems reasonable when patients desire to know the physician’s opinion.

Follow-Up

The patient decided not to return to the physician to seek care and died within 6 months of this interaction.

Disclaimer: The advice offered in this ethical consultation feature is based solely on the information supplied by readers, and is offered without benefit of a detailed patient history or physical or laboratory findings. The information is offered as a discussion of ethical issues and is not intended to be medical or legal advice and, therefore, should not be considered complete or used in place of a formal ethics consultation or in place of seeking advice from your ethics committee, legal counsel, or other available resources. One should never disregard or change medical advice or delay in providing it because of something that is printed here. The opinions expressed here are only those of the author and do not reflect the viewpoint of Cancer Network.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by Neil Wilson | August 25, 2012 12:04 AM EDT

I agree that the physician trained in what may be called orthdox evidence based medicine is under no obligation to discuss unproven often totally unscientific 'alternatives'. If asked about a another 'alternative' then the physician must be utterly polite about the issue and simply state that they cannot comment on the issue. If pressed firmly to comment then it is not wrong to say that one does not believe it will offer any more than placebo effect at best and possibly added toxicity if combined with an orthodox treatment.

by Rebecca Bechhold | August 22, 2012 9:53 AM EDT

The fact that this patient is from Germany is a cultural tip off. Alternative and complementary tharapies are much more commonly used in Europe.It is not surprising that he wanted to explore non-traditional options. Ideally, the patient would have brought up the subject at the time of the initial consultation so the oncologist could discuss their role in his treatment. Would have saved the emotional ordeal for the patient and the doctor.

Consultations in Ethics

What Are My Responsibilities to Inform?

Hard Choices

A Patient “Disrespected”

Am I Obligated to Give Therapy Against My Better Judgment?

A Wife Asks for Futile Therapy for Her Husband, a “Fighter”: How to Respond?

Don't Tell Me Anything Negative






 
RELATED CONTENT

Don't Tell Me Anything Negative
ONCOLOGY,  May 15, 2013
A Common Theme Among Ethical Issues in Oncology: The Need to Individualize Advanced Cancer Care
ONCOLOGY,  February 15, 2013
Rationing Healthcare: Who's Responsible?
ONCOLOGY,  February 15, 2013
Ethical Challenges in Oncology, Explored Through a Series of Vignettes
ONCOLOGY,  February 15, 2013
Ethics of Cost Containment for Cancer Therapies
August 23, 2012
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • A 49-Year-Old Woman Develops Thickened and Bound-Down Skin
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • US Task Force Recommends Breast Cancer Medications for High-Risk Women
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Preventing Exposure to Hazardous Drugs
  • Conflicts of Interest in Medicine: What About Ties to Payers?
  • Planning Treatment for Women With Recurrent Epithelial Ovarian Cancer
  • Rising PSA Level in a 46-Year-Old Man
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Ethics In Oncology
Evidence on Ethics In Oncology
Guidelines on Ethics In Oncology
Patient Education on Ethics In Oncology
Clinical Trials on Ethics In Oncology
Practical Articles on Ethics In Oncology
Research and Reviews on Ethics In Oncology
All "Ethics In Oncology" results


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy